News & Articles
The month of May is Asthma and Allergy Awareness month. We take this opportunity to celebrate all the pulmonologists that the Will Rogers Institute has worked with since creating a research and training center at the former Will Rogers Memorial Hospital (a tuberculosis treatment and rehabilitation center). As we know from the COVID-19 news, the […]Continue reading
NYUSOM: Drs. Kugler, Rom and Munger Current treatment of idiopathic pulmonary fibrosis (IPF) does not prolong survival. Development of new therapeutic approaches requires improved understanding of the pathogenesis of IPF. We have learned that ‘hedgehog’ (HH) signaling is required for lung development and may be highly relevant to IPF. The clinically-approved HH pathway antagonists Vismodegib […]Continue reading
Respiratory Distress Syndrome (RDS) is a serious condition that most often afflicts premature infants, although other babies can also have the condition. These infants are unable to breathe properly without oxygen and other medical interventions. The syndrome can be deadly, but with the right treatment, infants often survive and thrive. When RDS cannot be prevented, […]Continue reading
To perpetuate the memory of Will Rogers by promoting and funding medical research of cardiopulmonary diseases, purchasing neonatal ventilator equipment for medical facilities across the country and by educating the general public on topics of health and fitness.